By Kate Burba
BOSTON — A new model forecasted a “substantial clinical burden” of metabolic dysfunction-associated steatotic liver disease in the next 30 years, including twice as many cases of liver cancer and triple the need for liver transplantation.
“The prevalence of NAFLD has been increasing significantly both worldwide and in the U.S.,” Phuc Le, PhD, MPH, assistant professor of medicine at Cleveland Clinic Lerner College of Medicine, said at The Liver Meeting media briefing. Read the full article in Healio.